Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Tricalm Hydrogel

Phase 2Small molecule

UUniversity of California, San Diego

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q4 2028

Phase 2Recruiting

Pruritus

NCT06748404

Clinical

Trials by Indication[1]

Pruritus1 trial

A Phase 2 Randomized Study of TriCalm Hydrogel® in the Treatment of Immunotherapy-Related Pruritus

Recruiting·UUniversity of California, San Diego·Phase 2·NCT06748404·28 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Tricalm Hydrogel. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Tricalm Hydrogel compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Tricalm Hydrogel. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of California, San Diego company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: UUniversity of California, San Diego

Related News